Market Signal Briefing

November 18, 2025 3:33 PM EST | Source: Bleichmar Fonti & Auld
New York, New York--(Newsfile Corp. - November 18, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against CarMax, Inc. (NYSE: KMX) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws.

If you invested in CarMax, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/carmax-inc-class-action-lawsuit.

Investors have until January 2, 2026, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in CarMax securities. The case is pending in the U.S. District Court for the District of Maryland and is captioned Jason Cap v. CarMax, Inc., et al., No. 1:25-cv-03602.

Why is CarMax Being Sued for Securities Fraud?

CarMax sells used cars. During the relevant period, the Company touted the strong and sustainable demand for its cars, driven by factors such as a seamless customer experience.

As alleged, in truth, it appears that the announcement of U.S. tariffs imposed on cars provided a short-term boost to demand, as customers purchased cars prior to the tariffs taking effect.

BFA Law is also investigating the unexpected departure of CEO Bill Nash on November 6, 2025, and whether CarMax properly assessed or reserved for its portfolio of car loans.

Why did CarMax's Stock Drop?

On September 25, 2025, the Company reported disappointing financial results for the second quarter of its fiscal year 2026. Specifically, CarMax announced sales declines across the board, including a 5.4% decline in retail used unit sales, a 6.3% decline in comparable store used unit sales, and a 2.2% decline in wholesale units. The Company also posted a disappointing second quarter net income of about $95.4 million, down from $132.8 million over the prior year. A main reason for the declines, according to CarMax, was a "pull forward" in demand into the first fiscal quarter due to the announcement of tariffs.

On this news, the price of CarMax stock dropped $11.45 per share, or roughly 20%, from $57.05 per share on September 24, 2025, to $45.60 per share on September 25, 2025.

Then, on November 6, 2025, CarMax announced the unexpected departure of CEO Bill Nash and a weak preliminary Q3 2025 outlook. On this news, the price of CarMax stock dropped over 24%.

Click here for more information: https://www.bfalaw.com/cases/carmax-inc-class-action-lawsuit.

What Can You Do?

If you invested in CarMax you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:

https://www.bfalaw.com/cases/carmax-inc-class-action-lawsuit

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named "Elite Trial Lawyers" by the National Law Journal, among the top "500 Leading Plaintiff Financial Lawyers" by Lawdragon, "Titans of the Plaintiffs' Bar" by Law360 and "SuperLawyers" by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.'s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.

https://www.bfalaw.com/cases/carmax-inc-class-action-lawsuit

Attorney advertising. Past results do not guarantee future outcomes.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/274881

November 18, 2025 3:33 PM EST | Source: Bleichmar Fonti & Auld
New York, New York--(Newsfile Corp. - November 18, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against MoonLake Immunotherapeutics (NASDAQ: MLTX) and certain of the Company's senior executives for potential violations of the federal securities laws.

If you invested in MoonLake, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/moonlake-immunotherapeutics-class-action-lawsuit.

Investors have until December 15, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in MoonLake common stock. The case is pending in the U.S. District Court for the Southern District of New York and is captioned Peters v. MoonLake Immunotherapeutics, et al., No. 1:25-cv-08612.

Why Was MoonLake Sued for Securities Fraud?

MoonLake is a clinical-stage biotechnology company focused on developing therapies for inflammatory diseases. During the relevant period, MoonLake conducted highly anticipated Phase 3 VELA trials for sonelokimab ("SLK"), an investigational therapeutic designed to treat adult participants with moderate to severe hidradenitis suppurativa ("HS").

MoonLake told investors that its "strong clinical data," including results from its Phase 2 MIRA trial, translate into "higher clinical responses for patients, and provide ample opportunity for differentiation of sonelokimab versus all competitors." The Company also stated that SLK's Nanobody structure differed in beneficial ways from traditional monoclonal antibody treatments from its competitors.

As alleged, in truth, the Company's clinical data and Nanobody structure did not confer a superior clinical benefit over its competitors, calling into question the drug's chances for regulatory approval and commercial viability.

The Stock Declines as the Truth Is Revealed

On September 28, 2025, MoonLake reported its week 16 results of the VELA Phase 3 trials. The Company reported disappointing results for both trials, with VELA-2 failing to meet its primary endpoint, calling into question the drug's chances for regulatory approval and commercial viability. On this news, the price of MoonLake stock fell $55.75 per share, or nearly 90%, from $61.99 per share on September 26, 2025, to $6.24 per share on September 29, 2025, the following trading day.

Click here for more information: https://www.bfalaw.com/cases/moonlake-immunotherapeutics-class-action-lawsuit.

What Can You Do?

If you invested in MoonLake you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:

https://www.bfalaw.com/cases/moonlake-immunotherapeutics-class-action-lawsuit

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named "Elite Trial Lawyers" by the National Law Journal, among the top "500 Leading Plaintiff Financial Lawyers" by Lawdragon, "Titans of the Plaintiffs' Bar" by Law360 and "SuperLawyers" by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.'s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.

https://www.bfalaw.com/cases/moonlake-immunotherapeutics-class-action-lawsuit

Attorney advertising. Past results do not guarantee future outcomes.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/274884

November 18, 2025 3:33 PM EST | Source: Bleichmar Fonti & Auld
New York, New York--(Newsfile Corp. - November 18, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Freeport-McMoRan Inc. (NYSE: FCX) and certain of the Company's senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws.

If you invested in Freeport, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/freeport-mcmoran-inc-class-action-lawsuit.

Investors have until January 12, 2026, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Freeport securities. The case is pending in the U.S. District Court for the District of Arizona and is captioned Reed v. Freeport-McMoRan Inc., et al., No. 2:25-cv-04243.

Why is Freeport Being Sued for Securities Fraud?

Freeport is a mining company with its Indonesian affiliate operating as PT Freeport Indonesia ("PTFI"). PTFI operates the Grasberg Copper and Gold Mine ("Grasberg"), in which the Indonesian government holds a commercial interest. During the relevant period, Freeport touted its safety procedures, including its use of data and technology as well as behavioral science principles to prevent fatal incidents. It indicated it provides the training, tools, and resources needed to identify risks and consistently apply effective controls.

As alleged, in truth, Freeport overstated its commitment to safety, given that it conducted unsafe mining practices at the Grasberg mine which were reasonably likely to result in worker fatalities.

Why did Freeport's Stock Drop?

On September 9, 2025, Freeport issued a press release on its PTFI operations. It announced that mining operations in Grasberg had been suspended to evacuate seven team members that were trapped due to a landslide at one of its underground mines. This news caused the price of Freeport stock to drop $2.77 per share, or more than 5.9%, from a closing price of $46.66 per share on September 8, 2025, to $43.89 per share on September 9, 2025.

On September 24, 2025, Freeport issued an update on the incident noting that two of the seven individuals had been fatally injured and that the remaining five team members remained missing. In the same release, Freeport noted that due to the suspension in operations, sales were expected to be 4% lower for copper and approximately 6% lower for gold than July 2025 estimates. This news caused the price of Freeport stock to drop $7.69 per share, or almost 17%, from a closing price of $45.36 per share on September 23, 2025, to $37.67 per share on September 24, 2025.

Then, on September 25, 2025, Bloomberg reported that the incident and halt in production was straining the relationship between Freeport and Indonesia, that "the Jakarta government [had already been] looking to take greater control," and that government officials may increase its demand for an increased share. This news caused the price of Freeport stock to drop $2.33 per share, or more than 6%, from a closing price of to $37.67 per share on September 24, 2025, to $35.34 per share on September 25, 2025.

Finally, on September 28, 2025, an Indonesian news organization reported that the incident was preventable, not just a natural disaster. The article quotes an Indonesian professor stating that "the landslide, often termed a mud rush, is a known flow of mud and rocks from the mine cavity, a risk long associated with certain mining methods." The professor stated, "[i]n other words, this danger is not new and should have been anticipated from the beginning[.]"

Click here for more information: https://www.bfalaw.com/cases/freeport-mcmoran-inc-class-action-lawsuit.

What Can You Do?

If you invested in Freeport you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:

https://www.bfalaw.com/cases/freeport-mcmoran-inc-class-action-lawsuit

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named "Elite Trial Lawyers" by the National Law Journal, among the top "500 Leading Plaintiff Financial Lawyers" by Lawdragon, "Titans of the Plaintiffs' Bar" by Law360 and "SuperLawyers" by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.'s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.

https://www.bfalaw.com/cases/freeport-mcmoran-inc-class-action-lawsuit

Attorney advertising. Past results do not guarantee future outcomes.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/274904

NFLX's 90% price drop stems solely from its 10-for-1 split as the company enters a new phase backed by strong operational momentum. Hold the stock for now.

SummaryOne Liberty Properties remains a Buy, offering an attractive yield and solid upside potential despite recent price declines and macro headwinds.One Liberty Properties' transition to industrial properties and strong 98.2% occupancy support its portfolio, but the high ~96.7% AFFO payout ratio today poses dividend safety concerns, for now.One Liberty Properties benefits from very high insider ownership, well-laddered fixed-rate debt, and asset recycling initiatives, which enhance margin of safety and future growth prospects.While near-term risks from delayed rate cuts and execution remain, One Liberty Properties' valuation and potential for recovery make it appealing for patient investors. Richard Drury/DigitalVision via Getty Images

Introduction Back when I first covered One Liberty Properties (OLP), I rated them a Buy, highlighting their transition to industrial properties supported by recent acquisitions and asset sales, offering a compelling dividend yield that's, however, not

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in OLP over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

SAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements concerning Stride business and prospects, resulting in its stock trading at inflated prices.

NEW YORK--(BUSINESS WIRE)--Tradeweb Markets Inc. (Nasdaq: TW), a leading, global operator of electronic marketplaces for rates, credit, equities and money markets, today announced it will present at the Goldman Sachs 2025 U.S. Financial Services Conference. Tradeweb CEO Billy Hult is scheduled to participate in a fireside chat on Wednesday, December 10, 2025 at 10:40 AM EST. A live webcast of the session will be available via https://investors.tradeweb.com/events-and-presentations. A replay wil.

Michelob Ultra owner is in talks to buy boxed punch that has gained traction with younger drinkers.

Shares of Palladyne AI Corp. (PDYN - Free Report) have declined 17.5% since the company reported its earnings for the quarter ended Sept. 30, 2025. This compares to the S&P 500 index’s 1.9% decline over the same time frame. Over the past month, the stock has declined 36.7% compared with the S&P 500’s 0.1% growth.

Palladyne AI incurred a third-quarter 2025 loss of 9 cents, narrower than a loss of 27 cents per share in the third quarter of 2024.

Revenue of $0.9 million reflected a marginal year-over-year decline of 1.3%. 

On the profitability front, the company incurred a net loss of $3.7 million, significantly narrower than the $7.1 million loss recorded in the year-ago quarter. This improvement was largely driven by a favorable swing in warrant-related gains.

Total operating expenses rose to $8.9 million from $8.2 million a year ago, primarily driven by increased investment in research and development (R&D), which rose 21.8% to $3.2 million. Meanwhile, general and administrative expenses saw a modest rise, and sales and marketing expenses dipped slightly. Interest income more than doubled, contributing to improved bottom-line results. Notably, the company reported a $3.8 million gain on warrant liabilities this quarter, versus a loss of $0.04 million in the same period last year.

Other Key Business MetricsPalladyne ended the quarter with $57.1 million in cash, cash equivalents and marketable securities, and maintained a debt-free balance sheet, a position it described as offering a “multi-year operating runway”. Operating cash usage stood at $6.3 million for the quarter, in line with management’s expectations and prior periods.

The company also issued 8.2 million additional shares over the nine-month period, helping to boost its equity position from a deficit of $9.5 million at the end of 2024 to positive equity of $51.8 million as of Sept. 30, 2025. This increase was partly supported by a $29.1 million capital raise and $6.4 million from warrant exercises.

Management CommentaryCEO Ben Wolff characterized the quarter as a “defining phase” for Palladyne, emphasizing strategic alignment with evolving Department of War directives. He highlighted the growing relevance of the company’s closed-loop autonomy systems in national defense, especially through its platforms Palladyne IQ and Palladyne Pilot.

In the earnings call, management reiterated confidence in the potential of its strategic transformation, especially through acquisitions and partnerships such as GuideTech and Crucis. These were presented as foundational to the firm’s newly branded “Palladyne Defense” unit, enabling integrated delivery of AI, guidance systems, avionics and aerospace manufacturing.

Factors Influencing Headline NumbersRevenue stagnation was primarily due to unchanged commercial traction for Palladyne IQ, which remains in limited deployment and internal testing phases. Management did not indicate significant new commercial contracts during the quarter.

R&D expenses were elevated as the company invested in next-generation capabilities and software upgrades across its product portfolio, particularly the upcoming release of the next version of Palladyne IQ. CEO Ben Wolff acknowledged in the call that user interface challenges have delayed IQ V2’s deployment, although internal testing is ongoing.

Furthermore, the improvement in net income was significantly influenced by non-operating gains — particularly the $3.8 million gain on warrant liabilities — rather than core operational improvements.

Other DevelopmentsDuring the quarter, Palladyne was awarded U.S. Patent No. 12,452,957 for its closed-loop tasking and control architecture, aimed at strengthening its Palladyne Pilot platform. The company also expanded its collaboration with Draganfly to incorporate Palladyne Pilot into unmanned aerial vehicle (UAV) platforms, further embedding itself into defense-related applications. Significantly, Palladyne appointed Lieutenant General (Ret.) Stephen M. Twitty to its Board of Directors, enhancing its defense credentials.

Additionally, two acquisitions — GuideTech and Crucis — were finalized. GuideTech specializes in aerospace system design and integration, while Crucis is a U.S.-based manufacturer with a defense-heavy customer base, including Lockheed and Boeing. These acquisitions are intended to accelerate product development cycles and integrate Palladyne’s software across broader platforms under the newly established Palladyne Defense division.

SAN DIEGO, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Skye Bioscience, Inc. (NASDAQ: SKYE) securities between November 4, 2024 and October 3, 2025. Skye is a clinical stage biopharmaceutical company that focuses on developing molecules that modulate G protein-coupled receptors (“GPCRs”) to treat obesity, overweight, and metabolic diseases. The Company’s lead product candidate is nimacimab.

For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.

The Allegations: Robbins LLP is Investigating Allegations that Skye Bioscience, Inc. (SKYE) Misled Investors Regarding the Viability of its Lead Drug Candidate

According to the complaint, during the class period, defendants failed to disclose that (i) nimacimab was less effective than defendants had led investors to believe and (ii) accordingly, nimacimab’s clinical, regulatory, and commercial prospects were overstated.

Plaintiff alleges that on October 6, 2025, Skye issued a press release “announc[ing] the topline data from its 26-week Phase 2a CBeyond™ proof-of-concept study of nimacimab[.]” The press release disclosed that the “the nimacimab monotherapy arm did not achieve the primary endpoint of weight loss compared to placebo” and that “preliminary pharmacokinetic analysis showed lower than expected drug exposure, potentially indicating the need for higher dosing as a monotherapy.” On this news, Skye’s stock price fell $2.85 per share, or 60%, to close at $1.90 per share on October 6, 2025.

What Now: You may be eligible to participate in the class action against Skye Biosciences, Inc. Shareholders who wish to serve as lead plaintiff for the class must submit their papers with the court by January 16, 2026. The lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002.

To be notified if a class action against Skye Biosciences, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Key Takeaways CDE's 2025 gains reflect higher revenues, better margins and strong free-cash-flow expectations. Coeur's Q3 output rose with lower costs at key mines and a sharply strengthened cash position. CDE advanced exploration across Las Chispas, Kensington, Wharf and Palmarejo to extend resource.
Coeur Mining, Inc. (CDE - Free Report) has gained 152.7% year to date compared with the Zacks Mining-Non Ferrous industry’s 22.9% increase and the S&P 500’s modest 16% rise. The performance was underpinned by higher revenues, improved margins and expectations of free cash flow exceeding $550 million for the full year. 

Among its peers, Southern Copper Corporation (SCCO - Free Report) and Lundin Mining Corporation (LUNMF - Free Report) have witnessed a share price hike of 39.4% and 110.4%, respectively. 

Price Performance of CDE vs. Industry, S&P 500, SCCO, LUNMFImage Source: Zacks Investment Research

Technical indicators show that CDE has been trading below the 50-day and 200-day simple moving average (SMA). The 50-day SMA is reading higher than the 200-day SMA, indicating a bullish trend. 

Let’s look at the CDE’s fundamentals to analyze the stock better. 

Robust Mine Performance and Strengthened Cost ControlCoeur delivered a robust third quarter 2025 of combined production of 111,364 ounces of gold and 4.8 million ounces of silver. The reported adjusted cost is applicable to sales at about $1,215 per ounce of gold and around $14.95 per ounce of silver.  

Key mines like Las Chispas, Palmarejo, Kensington and Wharf all showed improvements. Wharf’s gold production rose 16% in the quarter, and Kensington’s cost per ounce improved to $1,659. Cost discipline is evident as several sites narrowed their full-year cost guidance, reflecting operational improvements and a positive approach.   

Financial Resilience Backed by Strong Cash Generation

The company’s financial transformation underpins a more resilient business model, deleveraging rapidly while still funding growth and returning capital. Coeur Mining ended the third quarter of 2025 with a significantly strengthened financial footing, holding $266.3 million in cash and equivalents, more than double its previous quarter's balance.  

Year to date, it has repaid over $228 million of debt, reducing its total debt to $363.5 million and bringing its net-leverage ratio down to a very conservative 0.1X, putting the company on track toward a near net-cash position. 

Coeur generated $237.7 million in cash flow from operating activities during the third quarter of 2025, reflecting an increase from $206.95 million in the previous quarter. This robust operating cash flow forms a foundation for Coeur’s capital deployment strategy, supporting capex, debt repayment and its shareholder return initiatives. 

CDE initiated a $75 million share repurchase program and has already repurchased nearly 10% of this authorization at an average price of $11.79 per share. This move not only reflects management’s confidence in the business but also indicates a disciplined approach to capital allocation. 

The company invested $49 million in capital expenditures, of which about 70% was allocated to sustaining capex and 30% toward development projects. Exploration spending totaled $30 million, with $25 million treated as an expense and $5 million capitalized, underscoring its strategy of both preserving existing reserves and pursuing growth opportunities. 

The cash cushion not only provides flexibility for further expansion or M&A but also reduces risk in a volatile commodity price environment. Coeur’s balanced capex strategy (sustaining vs development) suggests management is not just chasing growth, but also protecting its existing asset base.  

Coeur’s Broad-Based Growth and Exploration ProgressCoeur is aggressively advancing multiple growth fronts across its portfolio. At Las Chispas, infill and expansion drilling continue to pay off. In the third quarter of 2025, Coeur deployed up to six rigs underground and on the surface, and in the Las Chispas Block, it reported the new “Promesa” vein between the Augusta and William Tell zones. 

This work has strengthened Coeur’s confidence in extending Las Chispas’ mine life and bolstering its high-grade resource base. Meanwhile, at Kensington, exploration has uncovered new high-grade parallel vein zones, including drill intercepts of 7.1 feet at 11.5 oz/t gold in the Upper Kensington Zone. The Elmira deposit also continues to show expansion potential, with a newly identified hanging-wall mineralized zone (EHM). 

Coeur’s year-end 2024 reserves update showed substantial growth at both Wharf and Palmarejo. Wharf’s measured & indicated gold resources more than doubled, and inferred resources tripled, driven by its ongoing infill drilling and optimization initiatives.  

At Palmarejo, expansion drilling in the Hidalgo corridor has significantly extended inferred resource potential, with much of the 2025 exploration budget earmarked for these highly prospective, unconstrained areas.  

Coeur is also building optionality at Silvertip, its polymetallic project in British Columbia. In the first quarter of 2025, Coeur tripled its land package there and advanced its geological modeling ahead of a more intensive drill campaign. These coordinated development efforts, ramping up high-value drilling at Las Chispas and Kensington, extending the life of mine at Wharf and Palmarejo, and building foundational knowledge at Silvertip, illustrate a strategically balanced growth strategy. 

CDE’s Rising Earnings Estimates Reflect Positive SentimentsThe Zacks Consensus Estimate for 2025 and 2026 EPS has been revised upward over the past 60 days.

Image Source: Zacks Investment Research

The Zacks Consensus Estimate for fiscal 2025 earnings is currently pegged at 91 cents per share, suggesting year-over-year growth of 405.6%.  

Image Source: Zacks Investment Research

Coeur Trading Below Industry Coeur is currently trading at a forward 12-month price-to-sales multiple of 5.53X, above the peer group average of 3.65X and its five-year median.

Image Source: Zacks Investment Research

The forward 12-month price-to-sales multiples for Southern Copper and Lundin Mining are 8.47 and 4.36, respectively. 

Final Thought: Buy CDE for NowCoeur’s operational momentum, financial discipline and multi-asset growth pipeline position it as a materially stronger and more future-ready company than in prior years. The combination of rising production, declining unit costs, disciplined capital allocation, and a rapidly deleveraging balance sheet provides a compelling fundamental backdrop.  

The reduction of debt, strengthening of liquidity, reinvestment in high-return assets, and return of capital to shareholders combined with exploration success across Las Chispas, Kensington, Palmarejo, and Wharf that continues to expand the company’s long-term value potential make Coeur an increasingly attractive investment consideration for investors seeking both operational resilience and long-term upside in the gold-silver sector. Coeur currently carries a Zacks Rank #2 (Buy). 

You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. 

Shares of Espey Mfg. & Electronics Corp. (ESP - Free Report) have gained 1.1% since the company reported its earnings for the quarter ended Sept. 30, 2025. This compares to the S&P 500 index’s 2% decline over the same time frame. Over the past month, the stock has gained 1.7% compared with the S&P 500’s 0.2% growth.

Espey reported first-quarter fiscal 2026 net income of 76 cents per share, up from 61 cents per share in the prior-year period. 

Net sales of $9.1 million for the quarter reflected a 12.9% decline from the $10.4 million posted in the same quarter a year earlier. Despite the revenue contraction, net income rose to $2.2 million compared to $1.6 million in the prior-year period. 

Gross profit rose 14.9% to $3.2 million, pushing gross margin up to 35.4% from 26.8% in the year-ago quarter. The company also declared and paid total dividends of $1.00 per share, including a special dividend of 75 cents, up from 25 cents in the prior-year quarter.

Other Key Business MetricsThe jump in gross margin and profitability stemmed from improved product mix, labor efficiencies, and cost management. Operating income reached $2.1 million, up from $1.7 million in the prior-year quarter, even as selling, general and administrative expenses rose by 6.4% to $1.2 million. Interest income nearly doubled year over year to $0.5 million thanks to higher cash balances and investment yields. Total comprehensive income came in at $2.2 million, compared to $1.6 million a year ago.

Cash flow from operations was robust at $5.7 million, a significant increase from $1.4 million in the prior-year quarter, driven by higher customer advances and lower receivables. Capital expenditures totaled $1.3 million, offset by $1 million in milestone reimbursements under a Navy funding program.

Management CommentaryManagement attributed the lower sales to fewer deliveries and milestone completions tied to the product mix. Key contributors to the decline included the wind-down of a significant build-to-print program and lower shipments on select magnetics and power supply contracts. However, these were partially offset by increases in other core programs. The company emphasized that the sales decrease was not indicative of a long-term trend, but rather due to the timing of shipments.

Leadership remains confident in the company’s engineering and production capabilities, highlighting their vertically integrated model and commitment to delivering on military and industrial contracts. Operational efficiencies and procurement savings were also credited for the improvement in gross margins.

Factors Influencing the Headline NumbersEspey’s revenue model is heavily influenced by milestone-based and delivery-based billing. Of the $9.1 million in total net sales, $7.3 million was recognized based on units delivered and $1.8 million from milestone achievements. The decline in revenues compared to the prior year ($10.4 million total) was mainly due to fewer deliveries and milestone completions during the quarter. The company’s top five customers accounted for nearly 80% of total sales, up from 52% in the year-ago period, underscoring customer concentration.

Tax expense was $0.39 million, down slightly from the prior-year’s $0.4 million, resulting in an effective tax rate of 15.2%, lower than last year’s 20%. The decrease reflects tax benefits from employee stock ownership plan (ESOP) dividends, stock-based compensation, and deductions on foreign-derived intangible income (FDII).

Guidance Provided by ManagementEspey anticipates higher revenues for fiscal 2026 compared to fiscal 2025, supported by a healthy backlog of $141.1 million as of Sept. 30, 2025. Management expects at least $38.9 million of the backlog to convert into revenues by June 30, 2026. However, the company also indicated that new orders for fiscal 2026 may be lower than fiscal 2025’s total of $86.4 million, which had included two major multi-year awards.

First-quarter fiscal 2026 new orders totaled $10.5 million, up from $7.8 million in the same quarter last year. Espey noted approximately $161.5 million in outstanding opportunities across new and repeat business lines, but cautioned that awards remain subject to competitive bidding and U.S. defense spending dynamics.

Other DevelopmentsThe company continues to make progress on a $3.4 million Navy-funded capital improvement initiative aimed at enhancing test and qualification infrastructure. As of Sept. 30, 2025, Espey had received $1 million in milestone reimbursements and spent $1.9 million, with $0.6 million of equipment already placed in service. The project, based in Saratoga Springs, NY, is expected to be completed by fiscal year-end 2026 and requires Espey to contribute approximately $0.5 million of its own funds.

DoubleVerify Holdings, Inc. (DV) Global Technology, Internet, Media & Telecommunications Conference 2025 November 18, 2025 9:20 AM EST

Company Participants

Mark Zagorski - CEO & Director
Nicola Allais - Chief Financial Officer

Conference Call Participants

Matthew Swanson - RBC Capital Markets, Research Division

Presentation

Matthew Swanson
RBC Capital Markets, Research Division

[Audio Gap]

Day one of the RBC TIMT Tech Conference. Super excited to once again welcome back DoubleVerify. We have CEO, Mark Zagorski; and CFO, Nicola Allais.

Heading into 2025, big investment year for DoubleVerify is what we were talking about all through last Q4. I mean, looking back at the year, what are the achievements that were maybe the most impactful to the future of the company? And how did you feel like you're leaving this year better positioned in the current environment than where you entered?

Question-and-Answer Session

Mark Zagorski
CEO & Director

Yes. So when we kind of came in to '25 sought as a year of kind of transition and evolution and we had 2 main things that we wanted to focus on. First, extending our core value proposition, beyond just verification. And around midyear, we launched what we call the AdVantage Platform, which expanded our business not only to -- just to do more verification, but expanded into optimization. So algorithmic-based bidding compression and through performance measurement. So basically, this idea that we can verify an ad transaction, optimize or reduce the cost of that transaction and then prove whether or not those ads worked.

So we expanded the value proposition. Now that was one of our core tenets for the year. The second was to take our core value prop of verification and move that into entirely new spaces and evolve those spaces as well and specifically social CTV and the emerging AI advertising universe. And

Recommended For You

NEW YORK, Nov. 18, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Synopsys, Inc. (NASDAQ: SNPS) between December 4, 2024 and September 9, 2025, both dates inclusive (the “Class Period”), of the important December 30, 2025 lead plaintiff deadline.

SO WHAT: If you purchased Synopsys securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Synopsys class action, go to https://rosenlegal.com/submit-form/?case_id=44981 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 30, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, defendants failed to disclose to investors: (1) the extent to which Synopsys’ increased focus on artificial intelligence customers, which require additional customization, was deteriorating the economics of its Design IP business; (2) that, as a result, “certain road map and resource decisions” were unlikely to “yield their intended results,”; (3) that the foregoing had a material negative impact on financial results; and (4) as  a result of the foregoing, defendants’ positive statements about Synopsys’ business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Synopsys class action, go to https://rosenlegal.com/submit-form/?case_id=44981 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        [email protected]
        www.rosenlegal.com

Clean energy stocks are an interesting place to be in 2025. The new administration came in and changed the policy landscape surrounding renewables, cutting credits and financial support from the public sector. That said, renewables are still here, and many projects are still going forward. Indeed, a variety of factors are pushing renewable stocks forward despite those headwinds, helping the space perform for investors. One clean energy ETF, FRNW, may be of interest, particularly amid those trends.

The Fidelity Clean Energy ETF (FRNW) has returned 58.8% YTD, per YCharts data as of October 21. Over the last three months, as well, the clean energy ETF has returned 27%, suggesting continued momentum. How, then, has the fund produced those returns, and what might its outlook be for the rest of the year?

The ETF charges a 40 basis point fee for its approach. FRNW tracks the Fidelity Clean Energy Index, a market cap-weighted list of global clean energy companies. Perhaps the most intriguing part of the fund’s approach is its global view. While it does of course have a large focus on U.S. stocks, it can invest around the world.

See more: When Will Inflation Decrease? Why an Inflation ETF Can Help Now

Specifically, the fund invests in clean energy stocks from developed and emerging markets with a focus on some key areas. That includes areas like clean energy distribution, clean energy equipment manufacturing, and clean energy technology.

That has led the clean energy ETF to invest in clean energy stocks like Bloom Energy Corporation (BE). BE focuses on the manufacture and distribution of its natural gas or biogas power generation platform. It converts those energy sources into electricity without combustion.

BE has returned a remarkable 391% this year, according to YCharts data. The stock stands out as the largest equity stock in FRNW’s portfolio as of October 21st. The fund also invests in foreign clean energy firms like Spain-based EDP Renovaveis SA (EDRVF). The company, which focuses on wind power generation, has returned 53.9% YTD.

Together, stocks like those have helped the clean energy ETF perform and beat its peers. With continued investment outside the U.S. and rates falling domestically, the fund could potentially be poised for further enticing performance.

For more news, information, and strategy, visit the ETF Investing Content Hub.

Fidelity Investments® is an independent company unaffiliated with VettaFi LLC (“VettaFi”). These articles do not form any kind of legal partnership, agency affiliation, or similar relationship between VettaFi and Fidelity Investments, nor is such a relationship created or implied by the articles herein. VettaFi LLC is the author and owner of these articles.

1235112.1.0

Earn free CE credits and discover new strategies

Meta wins antitrust lawsuit over its acquisitions of WhatsApp and Instagram

By

Jacob Shamsian

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email.

Meta was victorious in an antitrust lawsuit brought by the FTC.

Arda Kucukkaya/Anadolu via Getty Images

2025-11-18T18:20:00.934Z

Meta wins antitrust lawsuit as judge rules FTC failed to prove monopoly claims.
FTC alleged Meta's Instagram and WhatsApp acquisitions harmed social networking competition.
The judge cited the evolving market and competition from TikTok in the decision.

A federal judge dealt a blow to the Federal Trade Commission on Tuesday, ruling against the agency in a blockbuster lawsuit against Meta.

US District Judge James Boasberg ruled that the FTC failed to prove Meta formed a monopoly through its purchases of Instagram and WhatsApp.

"The Court ultimately concludes that the agency has not carried its burden: Meta holds no monopoly in the relevant market," Boasberg wrote. "Judgment must therefore be entered in its favor."

The FTC's lawsuit, filed in 2020, alleged Meta's ownership of Instagram, WhatsApp, and Facebook meant the company illegally dominated the "personal social networking services" market. Government lawyers asked the judge to issue a ruling that would force Meta to divest from Instagram and WhatsApp.

Boasberg ruled that the "personal social networking services" market was too ill-defined. In rulings over the years, Boasberg said he noticed that Meta's apps — and the company's competitors — kept changing.

"The Court's two Opinions on motions to dismiss did not even mention the word 'TikTok,'" Boasberg wrote. "Today, that app holds center stage as Meta's fiercest rival."

This story is breaking and will be updated.

Mark Zuckerberg

Meta

WhatsApp

More

Instagram

Read next

CarMax Inc (NYSE:KMX) is facing a mixed outlook as recent securitization data and preliminary guidance for the next quarter highlight ongoing challenges in the used-car market, according Wedbush analysts.

The analysts have a ‘Neutral’ rating on the stock, with a 12-month price target of $40, after the company reported October trends from its CAF securitization trust.

According to Wedbush, October data showed “trends were soft for another month, with delinquency and net loss rates improving slightly month-over-month, while extension rates deteriorated sharply.”

The analysts wrote that while delinquency rates were above historical averages, they would have increased further if not for the impact of the new securitization.

“Results thus far are trending in line with management commentary, which suggests that delinquencies will continue to ramp through the rest of the year, before improving again during the tax refund period,” they wrote.

Since CarMax’s last quarterly report, consensus CAF income estimates for 2025 have fallen roughly 10%, reflecting investor concerns about credit exposure and management’s ability to maintain market leadership.

Wedbush added that it will continue to monitor the performance of CarMax’s portfolio to assess potential impacts on loan loss provisions and exposure to lower-tier consumers.

The company also announced a leadership change in early November, with CEO Bill Nash stepping down from his role and the Board effective December 1, the firm highlighted.  

CarMax shared preliminary guidance for Q3 fiscal 2026, signaling a slowdown in used-unit sales and lower earnings. The company expects comparable store used unit sales to decline between 8% and 12% year-over-year, below initial Street expectations of -4% by about 605 basis points at the midpoint, Wedbush noted.

Diluted EPS is projected in the range of $0.18 to $0.36, well under consensus estimates of $0.81, as CarMax navigates declining retail sales, sharp depreciation in the wholesale business, and higher marketing expenses.

On the financing side, CarMax priced its 2025-4 securitization in October with a collateral spread of about 5.3%, roughly 60 basis points higher than the July 2025-3 prime transaction.

The $1.3 billion deal featured a weighted average collateral coupon of 9.4% and an average credit score of 759, both modestly above the prior prime transaction. Wedbush noted that the deal size was smaller than the previous prime transaction but larger than the most recent non-prime securitization.

“Soft trends in CAF securitizations, combined with weaker preliminary guidance and leadership changes, suggest a cautious near-term environment for CarMax,” the analyst wrote.

Shares of Carmax traded hands at $33 on Tuesday afternoon, down almost 60% so far this year.

Jamf Holding (JAMF - Free Report) could be a solid choice for investors given the company's remarkably improving earnings outlook. While the stock has been a strong performer lately, this trend might continue since analysts are still raising their earnings estimates for the company.

The upward trend in estimate revisions for this company reflects growing optimism of analysts on its earnings prospects, which should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. Our stock rating tool -- the Zacks Rank -- has this insight at its core.

The five-grade Zacks Rank system, which ranges from a Zacks Rank #1 (Strong Buy) to a Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record of outperformance, with Zacks #1 Ranked stocks generating an average annual return of +25% since 2008.

Consensus earnings estimates for the next quarter and full year have moved considerably higher for Jamf Holding, as there has been strong agreement among the covering analysts in raising estimates.

The chart below shows the evolution of forward 12-month Zacks Consensus EPS estimate:

12 Month EPS

Current-Quarter Estimate RevisionsThe earnings estimate of $0.23 per share for the current quarter represents a change of +35.3% from the number reported a year ago.

Over the last 30 days, the Zacks Consensus Estimate for Jamf Holding has increased 6.25% because one estimate has moved higher while one has gone lower.

Current-Year Estimate RevisionsThe company is expected to earn $0.85 per share for the full year, which represents a change of +39.3% from the prior-year number.

In terms of estimate revisions, the trend for the current year also appears quite encouraging for Jamf Holding. Over the past month, three estimates have moved higher compared to no negative revisions, helping the consensus estimate increase 11.32%.

Favorable Zacks RankThanks to promising estimate revisions, Jamf Holding currently carries a Zacks Rank #2 (Buy). The Zacks Rank is a tried-and-tested rating tool that helps investors effectively harness the power of earnings estimate revisions and make the right investment decision.

You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

Our research shows that stocks with Zacks Rank #1 (Strong Buy) and 2 (Buy) significantly outperform the S&P 500.

Bottom LineInvestors have been betting on Jamf Holding because of its solid estimate revisions, as evident from the stock's 24.4% gain over the past four weeks. As its earnings growth prospects might push the stock higher, you may consider adding it to your portfolio right away.

Key Takeaways CP's earnings estimate for 2025 and 2026 has been revised lower over the past 60 days.
The company's shares have fallen 4.7% in a year, trailing the Transportation - Rail industry.
Canadian Pacific is grappling with elevated expenses and a volatile macro and tariff environment.
Canadian Pacific Kansas City Limited (CP - Free Report) is facing mounting pressure from increased expenses. Tariff-related woes are also hurting the company’s prospects, making it an unattractive choice for investors’ portfolios.

CP: Key Risks to WatchSouthward Earnings Estimate Revision:The Zacks Consensus Estimate for 2025 earnings has been revised 2.33% downward in the past 60 days. Meanwhile, for 2026, the consensus mark for earnings has been revised 2.53% downward in the same time frame.

The unfavorable estimate revision indicates brokers’ lack of confidence in the stock.

Dim Price Performance:  The company’s price trend reveals that its shares have fallen 4.7% over the past year compared with the Transportation - Rail industry’s 3.7% decline.

Image Source: Zacks Investment Research

Weak Zacks Rank: CP currently has a Zacks Rank #4 (Sell).

Bearish Industry Rank: The industry to which Canadian Pacific belongs currently has a Zacks Industry Rank of 207 (out of 243). Such an unfavorable rank places it in the bottom 14% of Zacks Industries. Studies show that 50% of a stock’s price movement is directly related to the performance of the industry group it belongs to.

A mediocre stock within a strong group is likely to outperform a robust stock in a weak industry. Hence, reckoning the industry’s performance becomes imperative.

Headwinds: CP is mired in significant challenges, dampening the company’s prospects. The increased expenses are weighing on the company’s bottom line. In the third quarter of 2025, the total operating expenses fell but remained at an elevated level of $2.33 billion.

Moreover, companies like CP are navigating a volatile macro environment marked by economic uncertainty, shifting tariff regulations and geopolitical tensions.

Stocks to ConsiderInvestors interested in the Zacks Transportation sector may consider Expeditors International of Washington (EXPD - Free Report) and SkyWest (SKYW - Free Report) .

EXPD currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

EXPD has an expected earnings growth rate of 2.3% for the current year.  The company has an encouraging earnings surprise history. Its earnings outpaced the Zacks Consensus Estimate in each of the trailing four quarters, delivering an average beat of 13.94%.

SKYW currently carries a Zacks Rank #2 (Buy).

SkyWest has an expected earnings growth rate of 33% for the current year. The company has an encouraging earnings surprise history. Its earnings topped the Zacks Consensus Estimate in each of the trailing four quarters, delivering an average beat of 21.2%.

Meta's acquisitions of Instagram and WhatsApp did not illegally stifle competition in social networking, a judge found, a major win for the tech giant.

Key Takeaways HIW plans to acquire the 411,000-square-foot 6Hundred at Legacy Union in Charlotte's Uptown CBD.The $223M deal expands its Legacy Union campus to roughly 1.6M square feet of Class AA office.HIW expects up to $18.5M in stabilized NOI, with in-place rents more than 20% below market.
Highwoods Properties (HIW - Free Report) is setting the stage for growth with the planned acquisition of 6Hundred at Legacy Union, a newly delivered 411,000-square-foot Class AA office tower in Charlotte’s Uptown CBD that is about 84% leased with a weighted average lease term of more than 12 years.

The roughly $223 million investment positions Highwoods to scale its presence in the strong BBD of Charlotte, leveraging a property with embedded upside and long-term cash-flow potential. The acquisition is slated to close in the next 30 days.

Strategic Fit in the PortfolioThe property resides within the Legacy Union mixed-use campus in Charlotte, where Highwoods already owns adjoining assets, including the Bank of America Tower and SIX50 South Tryon. With the acquisition, the company’s footprint at Legacy Union will expand to roughly 1.6 million square feet of Class AA office with more than 4,200 structured parking spaces. For Highwoods, a concentrated campus in a high-demand urban location allows for operational efficiencies, shared amenities and stronger leasing leverage.

HIW's Financial Outlook & Growth OpportunityHighwoods expects stabilized annual net operating income (NOI) of about $17.5-$18.5 million on both a GAAP and cash basis, with stabilization projected by 2027 (on a GAAP basis) and 2028 (on a cash basis). In the meantime, 6Hundred at Legacy Union is expected to yield approximately $10 million of GAAP NOI in 2026.

 The company plans to fund the deal in a leverage-neutral way using proceeds from non-core asset sales, helping to preserve balance-sheet flexibility. The fact that in-place rents are more than 20% below market offers meaningful upside as leases roll and market rents reset.

Bottom Line of HIWFor investors focused on office-REIT credit and CRE transition plays, the Highwoods deal represents a strategic upgrade, acquiring a high-quality asset in a top Sunbelt city, with embedded rental growth potential and immediate scale benefits. Execution will be key, but the acquisition aligns well with the company’s strategy to deploy capital into best-in-class business-district office assets and exit less favorable non-core properties.

In the past three months, shares of this Zacks Rank #2 (Buy) company have declined 5.7% against the industry's uptick of 1.0%. However, from a valuation perspective, we note that Highwoods shares are currently undervalued, as suggested by the Value Score of B.

Image Source: Zacks Investment Research

Other Stocks to ConsiderSome other top-ranked stocks from the broader REIT sector are Digital Realty Trust (DLR - Free Report) and Public Storage (PSA - Free Report) , each carrying a Zacks Rank #2 at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

 The Zacks Consensus Estimate for DLR’s 2025 FFO per share has moved 14 cents northward over the past month to $7.35.

The consensus estimate for PSA’s 2025 FFO per share has been revised 2 cents upward to $16.87 over the past month.

Note: Anything related to earnings presented in this write-up represents funds from operations (FFO), a widely used metric to gauge the performance of REITs.

The Investment Committee give you their top stocks to watch for the second half. Jenny Harrington also highlights her sale of WPP.

Northern Technologies International Corporation (NTIC) Q4 2025 Earnings Call November 18, 2025 9:00 AM EST

Company Participants

G. Lynch - President, CEO & Director
Matthew Wolsfeld - CFO & Corporate Secretary
Vineet Dalal

Conference Call Participants

Timothy Clarkson - Van Clemens & Co. Incorporated
Auguste Richard - Northland Capital Markets, Research Division
Zach Liggett

Presentation

Operator

Good day, and thank you for standing by. Welcome to NTIC's Fourth Quarter 2025 Earnings Conference Call and Webcast. [Operator Instructions] Today's conference is being recorded.

As part of the discussion today, the representatives from NTIC will be making certain forward-looking statements regarding NTIC's future financial and operating results as well as their business plans, objectives and expectations. Please be advised that these forward-looking statements are covered under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and that NTIC desires to avail itself of the protections of the safe harbor for these statements.

Please also be advised that actual results could differ materially from those stated or implied by the forward-looking statements due to certain risks and uncertainties, including those described in NTIC's most recent annual report on Form 10-K, subsequent quarterly reports on Form 10-Q and recent press releases. Please read these reports and other future filings that NTIC will make with the SEC. NTIC disclaims any duty to update or revise its forward-looking statements.

I will now hand the conference call over to Mr. Patrick Lynch, NTIC's CEO. Please go ahead, sir.

G. Lynch
President, CEO & Director

Good morning. I'm Patrick Lynch, NTIC's CEO, and I'm here with Matt Wolsfeld, NTIC's CFO. Please note that a press release regarding our fourth quarter and full year fiscal 2025 financial results was issued earlier this morning and is available at ntic.com. During today's call, we will review various key aspects of our fiscal 2025 fourth quarter and

Recommended For You

The ETF industry continues to grow, with new funds arriving all the time. Each year, hundreds of ETFs arrive on the scene, from covered call ETFs to active bond ETFs and everything in between. State Street Investment Management has launched the latest ETF to join the ecosystem, adding a new leveraged loans ETF to play in the increasingly prominent leveraged loans space.

The major firm’s asset management arm launched the State Street SPDR S&P Leveraged Loan ETF (LVLN) this past week. According to a press release, the fund aims to offer broad exposure to the investable leveraged loans universe. In doing so, it will charge a gross expense ratio of 40 basis points (bps). Leveraged loans are high-risk loans provided to purchasers with poor credit or significant debt. 

Leveraged Loans ETF LVLN Arrives
Specifically, the fund aims to track the performance of the S&P USD Select Leveraged Loan Index. It includes U.S. dollar-denominated loans with a minimum of $500 million size, capping individual securities based on issuer and industry constraints as well as loan facility level. The index also applies liquidity filters as well as various market value weights.

“State Street Investment Management has one of the broadest index-based fixed income lineups, but continues to innovate to support advisors,” said VettaFi’s Head of Research Todd Rosenbluth. “The new ETF offers a low cost alternative to the firm’s popular actively managed SRLN.”

The State Street Blackstone Senior Loan ETF (SRLN) charges a 70 bps fee for its approach to short duration, noninvestment-grade, floating-rate senior debt of U.S. and non-U.S. firms. The fund, launched in 2013, has returned 8.4% over the last three years with its active approach. That performance beat its ETF Database Category average in that time. 

As the ETF ecosystem continues to morph and grow, funds like LVLN will arrive into an increasingly competitive landscape. In the meantime, however, coming from a shop as reputable as State Street, it may be worth watching in the intriguing leveraged loans ETF space.

For more news, information, and strategy, visit the ETF Strategist Content Hub.

Earn free CE credits and discover new strategies

Home Depot forecast a bigger drop in full-year profit after missing Wall Street estimates for quarterly earnings on Tuesday, as tariff-driven economic uncertainty dampened demand for big-ticket renovations and do-it-yourself projects.

The shift in tone from the company comes as executives said that a widely expected pick-up in demand from easing US interest and mortgage rates had failed to materialize, likely amplifying concerns over a slowing economy.

The world’s top home-improvement chain set the ball rolling for a week packed with earnings reports from big-box retailers, including Walmart and Target, as investors track consumer spending ahead of the all-important holiday season amid tariff-driven cost pressures.

Christopher Sadowski
Home Depot’s shares fell about 4% and those of rival Lowe’s declined 2%. Lowe’s is set to report results on Wednesday.

“Company’s margin performance remains soft due to increased operating expenses, tariffs on imported goods, rising wages, and logistics costs,” said Brian Mulberry, senior client portfolio manager at Zacks Investment Management.

Stalled housing market
Home Depot and Lowe’s have faced subdued demand as high mortgage rates prompted owners to stick to their homes and focus on essential repairs and shun big-ticket remodeling.

“We believe that consumer uncertainty and continued pressure in housing are disproportionately impacting home improvement demand,” CEO Ted Decker said in a statement.

“We believe that consumer uncertainty and continued pressure in housing are disproportionately impacting home improvement demand,” CEO Ted Decker. Home Depot
Home Depot projected annual adjusted earnings per share to decline 5%, compared with its prior target of a 2% drop year-on-year.

Annual same-store sales growth is expected to be “slightly positive,” compared with an August forecast of a 1% increase.

Home Depot’s comparable sales were largely flat in the third quarter, and comparable transactions fell 1.6%, as customers put off projects such as kitchen and bathroom remodels.

Home Depot’s comparable sales were largely flat in the third quarter, and comparable transactions fell 1.6%, as customers put off projects such as kitchen and bathroom remodels. Getty Images
Still, sales of $41.35 billion beat expectations of $41.10 billion, according to data compiled by LSEG.

Adjusted profit per share missed estimates for the third straight quarter, coming in at $3.74, compared with analysts’ expectations of $3.84.